BRPI0405651A - System and method for improved treatment of drug-based diseases - Google Patents

System and method for improved treatment of drug-based diseases

Info

Publication number
BRPI0405651A
BRPI0405651A BR0405651-5A BRPI0405651A BRPI0405651A BR PI0405651 A BRPI0405651 A BR PI0405651A BR PI0405651 A BRPI0405651 A BR PI0405651A BR PI0405651 A BRPI0405651 A BR PI0405651A
Authority
BR
Brazil
Prior art keywords
improved treatment
drug
based diseases
disease
health disorder
Prior art date
Application number
BR0405651-5A
Other languages
Portuguese (pt)
Inventor
Oscar Henrique Garcia Galvez
Marcus Augusto Ximenes Diniz
Original Assignee
Aventis Pharma Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0322661.0A external-priority patent/GB0322661D0/en
Application filed by Aventis Pharma Ltda filed Critical Aventis Pharma Ltda
Publication of BRPI0405651A publication Critical patent/BRPI0405651A/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies

Abstract

"SISTEMA E MéTODO PARA O TRATAMENTO APERFEIçOADO DE DOENçAS à BASE DE MEDICAMENTO". A presente invenção se refere a um método no qual se adquire e se usa os dados relativos a uma doença ou disfunção de saúde, provendo, por meio de seu processamento em informações úteis, um tratamento otimizado para tal doença ou disfunção de saúde. Em um outro aspecto da presente invenção, o uso de tal método leva a um aumento nas vendas do medicamento para o tratamento de tal doença ou disfunção de saúde."SYSTEM AND METHOD FOR IMPROVED TREATMENT OF MEDICINE-BASED DISEASES". The present invention relates to a method in which data relating to a disease or health disorder is acquired and used, providing, through its processing into useful information, optimal treatment for such disease or health disorder. In another aspect of the present invention, the use of such a method leads to an increase in sales of the medicament for treating such a disease or health disorder.

BR0405651-5A 2003-05-01 2004-04-27 System and method for improved treatment of drug-based diseases BRPI0405651A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46708203P 2003-05-01 2003-05-01
GBGB0322661.0A GB0322661D0 (en) 2003-05-01 2003-09-29 System and method for enhanced medicament-based treatment of disease
PCT/IB2004/002327 WO2004098374A2 (en) 2003-05-01 2004-04-27 System and method for enhanced medicament-based treatment of disease

Publications (1)

Publication Number Publication Date
BRPI0405651A true BRPI0405651A (en) 2005-08-16

Family

ID=33436291

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0405651-5A BRPI0405651A (en) 2003-05-01 2004-04-27 System and method for improved treatment of drug-based diseases

Country Status (3)

Country Link
BR (1) BRPI0405651A (en)
CA (1) CA2515359A1 (en)
WO (1) WO2004098374A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients

Also Published As

Publication number Publication date
WO2004098374A3 (en) 2006-04-13
WO2004098374A2 (en) 2004-11-18
CA2515359A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
Knott et al. Increased lymphatic flow in the thoracic duct during manipulative intervention
BR0116370A (en) Compound, pharmaceutical composition, use of a compound, and method of treating an hppar-mediated disease or condition in a patient.
BRPI0416796A (en) organic compounds
BRPI0410296A (en) system and method for determining the efficacy of treatment of neurological disorders using electroencephalogram
BRPI0416829A (en) system and method for managing medical treatment
BR0116169A (en) Compound, pharmaceutical composition comprising such compound, process for preparing a pharmaceutical composition, use of the compounds, process for the prophylactic or therapeutic treatment of type ii diabetes and process for the preparation of the compound.
AR034678A1 (en) PROCESS OF TREATMENT OR PREVENTION OF AN ILLNESS OR DISORDER IN AN ANIMAL CAUSED BY MYCOPLASMA HYOPNEUMONIAE
UY27186A1 (en) PHARMACEUTICAL FORMULATION
BR0308482A (en) Implantable drug delivery system
BR0212809A (en) Gdf-8 Antibody Inhibitors and Uses
BRPI0418029A (en) cd40 antibody formulation and methods
BRPI0407427A (en) Method to treat a patient and to treat myelodysplasia
CY1109454T1 (en) Treatment for Alzheimer's disease and vascular cerebral amyloidopathy
BRPI0415397A (en) methods and reagents for the treatment of immunoinflammatory disorders
ATE454465T1 (en) IN VITRO METHOD FOR IDENTIFYING COMPOUNDS FOR CANCER THERAPY
DE60126495D1 (en) NUCLEIC ACID AND PROTEIN, CALLED 158P1D7, FOR THE TREATMENT AND DETECTION OF BOLL CANCER AND OTHER CANCER TYPES
ATE493127T1 (en) USE OF LEVO-ORNIDAZOLE FOR PRODUCING AN ANTIPARASIC INFECTIOUS AGENT
BRPI0408491A (en) treatment of alzheimer's disease
SE0102147D0 (en) New methods
BRPI0405651A (en) System and method for improved treatment of drug-based diseases
DE50100833D1 (en) USE OF 2-METHYL-THIAZOLIDINE-2,4-DICARBONIC ACID AND / OR ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR PRODUCING A MEDICINE FOR TREATING CANCER DISEASES
BR9807332A (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
BR0114655A (en) Method for identifying a combination of drugs for breast cancer treatment in an animal, Method for identifying a combination of breast cancer drugs in an animal, Method for identifying a combination of drugs for breast cancer prevention in an animal predisposed to said cancer, method for preventing breast cancer in an animal predisposed to said cancer, method for optimizing treatment of a breast cancer patient, method for optimizing a cancer prevention regimen in an animal, set useful for treating breast cancer in a patient in need of pharmaceutical composition and treatment for treating or preventing breast cancer
DE60335892D1 (en) PHARMACEUTICAL COMPOSITION RELATING TO THE PRODUCTION OF A MEDICAMENT FOR TREATMENT AND / OR PREVENTATION AND / OR OBSERVANCE OF FAT CONNECTION
DE602004016547D1 (en) 1,4-DIHYDROPYRIDINE COMPOUNDS, PHARMACEUTICAL COMPOUNDS, AND METHOD FOR THE TREATMENT OF CARDIAC DISORDER

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS FARMACEUTICA LTDA (BR/SP)

Free format text: NOME ALTERADO DE: AVENTIS PHARMA LTDA

B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2256 DE 01/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.